__NUXT_JSONP__("/drugs/Inotuzumab_Ozogamicin", (function(a,b,c,d,e){return {data:[{drug:{slug:b,emaEpar:[{activeSubstance:c,conditionIndication:"Besponsa is indicated as monotherapy for the treatment of adults with relapsed or refractory CD22-positive B cell precursor acute lymphoblastic leukaemia (ALL). Adult patients with Philadelphia chromosome positive (Ph+) relapsed or refractory B cell precursor ALL should have failed treatment with at least 1 tyrosine kinase inhibitor (TKI).",inn:c,marketingAuthorisationDate:"2017-06-28 00:00:00",marketingAuthorisationHolder:"Pfizer Europe MA EEIG",medicineName:a,url:"https:\u002F\u002Fwww.ema.europa.eu\u002Fen\u002Fmedicines\u002Fhuman\u002FEPAR\u002Fbesponsa"}],fdaDrugLabel:[{brand:a,indication:"1. INDICATIONS AND USAGE BESPONSA is indicated for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). BESPONSA is a CD22-directed antibody-drug conjugate (ADC) indicated for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). ( 1 )",manufacturer:"Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.",splSetId:"cc7014b1-c775-411d-b374-8113248b4077"}],id:b,nciThesaurus:{casRegistry:"635715-01-4",chebiId:"",chemicalFormula:"C73H96IN6O25S3",definition:"A CD22-targeted cytotoxic immunoconjugate composed of a humanized IgG4 anti-CD22 antibody covalently linked to N-acetyl-gamma-calicheamicin dimethyl hydrazide (CalichDMH) with potential antineoplastic activity. Inotuzumab ozogamicin is rapidly internalized upon binding of the antibody moiety to B cell-specific CD22 receptors, delivering the conjugated CalichDMH intracellularly; the CalichDMH moiety binds to the minor groove of DNA in a sequence-specific manner, resulting in double-strand DNA breaks and apoptosis. CalichDMH is a derivative of gamma calicheamicin, a cytotoxic antibiotic produced by the bacterium Micromonospora echinospora.",fdaUniiCode:"P93RUU11P7",identifier:"C71542",preferredName:d,semanticType:"Immunologic Factor",subclassOf:["C155713"],synonyms:[a,"CMC-544","INOTUZUMAB OZOGAMICIN",d,"WAY-207294","Way 207294"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FInotuzumab_Ozogamicin",extension:".json",createdAt:e,updatedAt:e}}],fetch:{},mutations:void 0}}("Besponsa","Inotuzumab_Ozogamicin","inotuzumab ozogamicin","Inotuzumab Ozogamicin","2021-10-30T13:43:42.163Z")));